RESUMO

Introduction. Several studies have shown population differences in head circumference (HC) that question the universal validity of the World Health Organization (WHO) standard to assess head growth. Objectives. To compare the Argentine reference charts for HC from 0 to 5 years of age with the WHO standards. Population and methods. The 3rd and 97th percentiles for HC based on the Argentine reference charts were compared with the corresponding WHO standard and the percentage of children classified as having microcephaly (HC < 3rd percentile of the WHO) and macrocephaly (HC > 97th percentile of the WHO) at specific ages between 0 and 5 years were estimated. Results. The comparison of the Argentine reference charts with the WHO standards shows that, in both males and females, at the 3rd percentile, the Argentine reference charts are below the WHO standards from 1 to 6 months of age, similar from 9 to 18 months of age, and then above until 60 months old. In relation to the 97th percentile, the Argentine reference charts are above the WHO standards from birth to 60 months in both boys and girls. Conclusions. The head size of Argentine children is different from that established by the WHO standards. The adoption of the WHO standards for our population increases the percentage of macrocephaly diagnosis at all ages.

Introducción. Diversos estudios han evidenciado diferencias poblacionales en el tamaño cefálico que cuestionan la validez universal del estándar de la Organización Mundial de la Salud (OMS) para evaluar el crecimiento cefálico. Objetivos. Comparar las referencias argentinas de perímetro cefálico (PC) de 0 a 5 años con los estándares de la OMS. Población y métodos. Se compararon los percentiles 3 y 97 de PC de las referencias argentinas con los correspondientes del estándar de la OMS y se calcularon los porcentajes de niños clasificados como microcefálicos (PC < percentil 3 de la OMS) y macrocefálicos (PC > percentil 97 de la OMS) a edades específicas entre el nacimiento y los 5 años de edad. Resultados. La comparación de las referencias argentinas con los estándares de la OMS, muestra que ­en ambos sexos­ en el percentil 3, desde el primer mes y hasta los 6 meses, las referencias argentinas se encuentran por debajo de los estándares de la OMS, son similares entre los 9 y 18 meses, y luego se ubican por encima hasta los 60 meses. En relación con el percentil 97, las referencias argentinas se ubican por encima de los estándares de la OMS desde el nacimiento hasta los 60 meses en ambos sexos. Conclusiones. El tamaño cefálico de los niños y niñas argentinos difiere del de los estándares de la OMS. La adopción de los estándares de la OMS en nuestra población incrementa el porcentaje de diagnóstico de macrocefalia a todas las edades.

Assuntos

RESUMO

Macrocephaly frequently occurs in single-gene disorders affecting the PI3K-AKT-MTOR pathway; however, epigenetic mutations, mosaicism, and copy number variations (CNVs) are emerging relevant causative factors, revealing a higher genetic heterogeneity than previously expected. The aim of this study was to investigate the role of rare CNVs in patients with macrocephaly and review genomic loci and known genes. We retrieved from the DECIPHER database de novo <500 kb CNVs reported on patients with macrocephaly; in four cases, a candidate gene for macrocephaly could be pinpointed: a known microcephaly gene-TRAPPC9, and three genes based on their functional roles-RALGAPB, RBMS3, and ZDHHC14. From the literature review, 28 pathogenic CNV genomic loci and over 300 known genes linked to macrocephaly were gathered. Among the genomic regions, 17 CNV loci (~61%) exhibited mirror phenotypes, that is, deletions and duplications having opposite effects on head size. Identifying structural variants affecting head size can be a preeminent source of information about pathways underlying brain development. In this study, we reviewed these genes and recurrent CNV loci associated with macrocephaly, as well as suggested novel potential candidate genes deserving further studies to endorse their involvement with this phenotype.

Assuntos

RESUMO

BACKGROUND: Modern human brains and skull shapes differ from other hominids. Brain growth disorders as micro- (ASPM, MCPH1) and macrocephaly (NFIX, GLI3) have been highlighted as relevant for the evolution in humans due to the impact in early brain development. Genes associated with macrocephaly have been reported to cause this change, for example NSD1 which causes Sotos syndrome. RESULTS: In this study we performed a systematic literature review, located the reported variants associated to Sotos syndrome along the gene domains, compared the sequences with close primates, calculated their similarity, Ka/Ks ratios, nucleotide diversity and selection, and analyzed the sequence and structural conservation with distant primates. We aimed to understand if NSD1 in humans differs from other primates since the evolution of NSD1 has not been analyzed in primates, nor if the localization of the mutations is limited to humans. Our study found that most variations causing Sotos syndrome are in exon 19, 22 and 10. In the primate comparison we did not detect Ka/Ks ratios > 1, but a high nucleotide diversity with non-synonymous variations in exons 10, 5, 9, 11 and 23, and sites under episodic selection in exon 5 and 23, and human, macaque/colobus/tarsier/galago and tarsier/lemur/colobus. Most of the domains are conserved in distant primates with a particular progressive development from a simple PWWP1 in O. garnetti to a complex structure in Human. CONCLUSION: NSD1 is a chromatin modifier that suggests that the selection could influence brain development during modern human evolution and is not present in other primates; however, nowadays the nucleotide diversity is associated with Sotos syndrome.

Assuntos

RESUMO

BACKGROUND: 2q37 deletion syndrome is a rare autosomal dominant disorder caused by deletions in the 2q37 cytobands leading to developmental delay, intellectual disability, behavioral abnormalities and dysmorphic craniofacial features with more than 115 patients described worldwide. CASE PRESENTATION: We describe a Colombian 3-year-old patient with verbal communication delay, umbilical hernia, facial dysmorphic features, hypotonia, and macrocephaly with normal magnetic resonance imaging. Microarray-based comparative genomic hybridization revealed a 5.9 Mb deletion in the 2q37.2 and 2q37.3 regions, eliminating 60 protein-coding genes in one of her chromosomes 2 and allowing the diagnosis of 2q37 deletion syndrome in this patient. Therapeutic interventions so far were the surgical correction of the umbilical hernia. CONCLUSIONS: Genetic tests are important tools for the diagnosis of clinically complex and infrequent conditions but also for timely diagnosis that allows appropriate surveillance, interventions, and genetic counseling. This case also provides information for expanding the phenotypical and genetic characterization of 2q37 deletion syndrome.

Assuntos

RESUMO

Middle-aged and old adults (≥ 50 years) diagnosed with Cowden syndrome (CS) with orofacial manifestations are uncommon. We describe a case of CS in a 53-year-old female showing "narrow bird-like" face, macrocephaly, acral keratoses, oral candidiasis, burning in the mouth, and multiple asymptomatic papillomatous lesions with a cobblestone pattern distributed on the alveolar ridge, tongue, buccal mucosa, and commissure. The histopathological features of lesions of the oral mucosa were those of papillary fibroepithelial hyperplasia. Immunohistochemistry revealed strong positivity for PTEN and p53 in most epithelial cells, while the expression of Bcl-2, S-100, and Ki-67 was weak/negative. According to a review conducted in PubMed, Web of Science, Embase, and Scopus for the analysis of reports of CS individuals ≥ 50 years with orofacial manifestations, 56 cases have been described in literature. Predilection for women was observed, with a female:male ratio of 2.3:1. Thirty-five (62.5%) individuals developed some malignant neoplasms. Oral health providers should be aware of the orofacial aspects of CS, including multiple papillomatosis, which can be an important criterion for diagnosis. Since malignancies may occur in older adults with CS, the need for strict surveillance is necessary. The present case has been under follow-up for 7 years without evidence of other manifestations.

Assuntos

RESUMO

Untreated congenital toxoplasmosis remains an important cause of neurologic and ocular disease worldwide. However, congenitally infected infants may not have signs and symptoms their physicians recognize, leading to delayed diagnosis and missed opportunities for treatment. We describe a pair of twins diagnosed with congenital toxoplasmosis at 11 months of age following incidental detection of leukocoria in one twin.

Assuntos

RESUMO

INTRODUCTION: In utero Zika virus (ZIKV) exposure has been related to a group of congenital structural abnormalities called the congenital Zika syndrome, which also has been related to neurodevelopment alterations even in normocephalic children. Physical growth has been less explored, and delayed growth and malnutrition have been reported. OBJECTIVE: The objective of this study is to describe the growth and neurodevelopment features of normocephalic infants born from a cohort of mothers with RT-PCR confirmed ZIKV during pregnancy in Risaralda, Colombia. METHODS: We conducted a retrospective cohort, including normocephalic children born from mothers with RT-PCR confirmed ZIKV infection during pregnancy in Risaralda, Colombia. Physical growth was measured using WHO standards, and neurodevelopment was measured with the abbreviated neurodevelopment scale 2 validated for Colombia. RESULTS: After verifying inclusion and exclusion criteria, 16 children were followed during a median time of 28 months (IQR 23-31 months); for a total of 116 visits, 87.5% (n = 14) of the patients developed a growth alteration. Five presented post-natal microcephaly, and among them, four presented malnutrition or low height. Six patients developed macrocephaly. Patients with a normal head circumference had normal neurodevelopment. Only one patient with microcephaly persisted with impairment of the neurodevelopment at the end of follow-up. All the patients with macrocephaly had normal neurodevelopment. DISCUSSION: Our study suggests that growth could be altered in infants with in utero Zika exposure. We found a high proportion of patients with overgrowth and macrocephaly. Future studies should consider endocrine follow-up of children born with in utero Zika exposure to explore these findings' possible aetiologies. CONCLUSION: We found a high proportion of growth alterations, particularly with overgrowth features and macrocephaly. Our study suggests that in addition to neurodevelopment impairment, growth could be altered in infants and children with in utero Zika exposure, even in those patients born without CZS.

Assuntos

RESUMO

Abstract Introduction: Glutaric Aciduria Type 1 (GA-1) is produced by the enzymatic deficiency of glutaryl-CoA-dehydrogenase (GCDH), leading to the accumulation of glutaric acid (GA). 90% of patients without early treatment present acute encephalopathic crisis (AEC), followed by disabling neurological symptoms. The treatment consists of a low lysine (Lys) diet, protein substitute lys-free, tryptophan-reduced (PS) and L-carnitine. Objectives: Describe the clinical and nutritional evolution of a cohort of GA-1 patients at a national referral center in Chile. Methodology: Retrospective study of 24 patients diagnosed with GA-1 between 1998-2020 and referred to the Institute of Nutrition and Food Technology (INTA) of University of Chile. Results: Age at diagnosis was 19±27 months; 10/24 presented AEC and neurological sequelae. The cases without AEC (14/24) 8 presented neurological compromise: psychomotor development delay, abnormal movements and pyramidal syndrome. Nutritional evaluation: 12/24 were malnourished by deficiency, <6 years old group (12/24): 11 cases were found to have Lys and PS, ≥6 years old (12/24): 9/12 did not receive PS. All had normal free carnitine levels. Conclusion: GA-1 has variable symptoms with neurological involvement AEC or insidious start. Is essential to maintain a long-term follow-up and consider its inclusion in neonatal screening programs.

RESUMO

Alteration of the KPTN gene, responsible for the coding of kaptin (a protein involved in actin cytoskeletal dynamics), causes a syndrome characterized by macrocephaly, neurodevelopmental delay and epileptic seizures. We report the first Brazilian case of KPTN gene variation, previously described in nine subjects from four interlinked families from an Amish community in Ohio, two Estonian siblings and a 9-year-old boy from Kansas City. We report a case of KPTN-related syndrome in a 5-year-old child which presented macrocephaly, muscular hypotonia, and global development delay. The neurological examination revealed below-expected performance in coordination and balance tests, dyspraxia, and hand-mouth synkinesia. Expressive language was characterized by phono-articulatory imprecision, abundance of phonological processes and morphosyntactic immaturity. Neuropsychological assessment revealed intellectual disability with impairment of verbal and executive functions. Exome sequencing was performed. Analysis revealed a homozygous 2-nucleotide duplication c.597_598dup p.(Ser200Ilefs*55) in the KPTN gene, which is predicted to lead to a translational frameshift and formation of a premature stop codon. The phenotypic profile is similar to the cases described in the other families. Presence of macrocephaly and delayed development indicate the possibility of KPTN gene variation. Genetic testing should be carried out at an early stage in order to reach a timely diagnosis.

Assuntos

RESUMO

Objetivo: Determinar la incidencia de macrocefalia neonatal en un hospital de tercer nivel en Lima, Perú. Material y Métodos: Se definió macrocefalia en función al perímetro cefálico mayor que el percentil 97 para la edad y sexo. La información fue obtenida de los registros del Sistema Informático Perinatal del Hospital Cayetano Heredia durante el periodo 1º de enero, 2016 a 31 de diciembre, 2017. Se usó la Tabla Fenton para determinar los límites de normalidad. Resultados: Se registraron 210 casos de macrocefalia neonatal y una tasa general de 26 por mil nacidos vivos, inversamente proporcional a la edad gestacional. Conclusiones: la macrocefalia es más frecuente en prematuros, con un factor de riesgo cinco veces mayor en este grupo poblacional.

Objective: To determine the incidence of neonatal macrocephaly in a third level hospital from Lima, Perú. Methods: Macrocephaly was defined on the basis of a cephalic perimeter higher than the 97th percentile for age and sex. The report records of the Perinatal Computer System of Cayetano Heredia Hospital between January 1st., 2016 and December 31st, 2017 were used, as well as the Fenton growth chart to determine the limits of normality. Results: A total of 210 cases of neonatal macrocephaly was registered, a general rate of 26 per 1,000 live births. Neonatal macrocephaly incidence were inversely proportional to gestational age. Conclusions: Macrocephaly was higher in preterm neonates, with a risk factor five times higher in this population group.

RESUMO

Resumen La circunferencia cefálica (CC) es una medición que detecta alteraciones del crecimiento adecuado del cerebro. Las curvas de CC más utilizadas mundialmente son las propuestas por los CDC, NCHS y OMS. A pesar de las críticas sobre la metodología para crearlas, se han hecho actualizaciones para corregir inconsistencias. Esto ha servido para detectar y tratar oportunamente problemas de tamaño craneal tanto en los extremos pequeños (microcefalia) o grandes (macrocefalia). Algunos autores opinan que existe la necesidad de contar con curvas regionales para mejorar el valor diagnóstico de éstas en cada población. Otros, como Kenton Holden y colaboradores, han propuesto nuevas curvas que consolidan diferentes bases de datos con el objetivo de reducir el riesgo de errores en el diagnóstico de microcefalia o macrocefalia leve. Es necesario estudiar cuál es el patrón de crecimiento craneal normal de niños/as latinoamericanos por cada región o país, así como conocer las diferencias interétnicas.

Abstract The cephalic circumference (CC) is a measurement that detects alterations in the proper growth of the brain. CC curves most used worldwide are those proposed by the CDC, NCHS and WHO. Despite criticism of the methodology used to create them, updates have been made to correct inconsistencies, and that has helped to detect and treat on time problems of cranial size at both the small (microcephaly) and large (macrocephaly) ends. Several authors have suggested that regional reference curves should be made, and others, like Kenton Holden and colleagues, have proposed new curves that consolidate different databases, aiming to reduce the risk of errors in the diagnosis of microcephaly or mild macrocephaly. It is necessary to study what the normal cranial growth pattern of Latin American children is for each region or country, as well as to determine the interethnic differences.

RESUMO

In a wide spectrum of cases in childhood, macrocephaly does not carry a neurological risk, although a range of possibilities will have an impact on both the evolutionary and cognitive aspects of children. The previous happens in pathologies with progressive components, such as tumors or hydrocephalus, and in those cases in which the factor of the growth of the cephalic perimeter is given by structural components of the nervous system as it happens in megalocephaly. As in all other medical acts, the careful taking of the anamnesis, the appropriate neurological examination and the valuations of the neurodevelopment items can give a thorough orientation about the etiology and importance of the problem. The help of diagnostic aids as well as images will provide the other data to define the diagnosis and propose a treatment.

Assuntos

RESUMO

El síndrome de Silver-Russell es una condición infrecuente que clínicamente se manifiesta por macrocefalia relativa, dismorfias faciales, restricción importante de crecimiento pre-y postnatal y otros hallazgos variables al examen físico. En un 60% de los pacientes el estudio genético actualmente disponible permite establecer el diagnostico, sin embargo prevalecen los criterios clínicos. Se presenta el caso clínico de un paciente evaluado al año de vida con historia de restricción de crecimiento prenatal y con talla baja y desnutrición crónica descompensada, en el cuál se descartaron otras etiologías y se concluye por criterios clínicos de padecer el síndrome, a pesar de un estudio genético negativo. Debido a un amplio espectro de manifestaciones clínicas a veces sutiles y confundentes se debe conocer este síndrome para su diagnóstico oportuno.

Silver-Russell syndrome is an uncommon condition that manifests itself as relative macrocephaly, facial dysmorphia, poor pre-and post-natal growth and other variable physical features. In 60% of patients it is possible to establish the diagnosis through available genetic testing; however, clinical criteria are more important. We present the clinical case of a patient with poor pre-natal growth, small size and chronic malnutrition evaluated at one year old where other etiologies were discounted and the syndrome diagnosed because of the clinical signs, despite genetic tests being negative. With its ample spectrum of sometimes subtle and confusing clinical signs, familiarity with this syndrome is key to reaching an early diagnosis.

RESUMO

El Síndrome de Morquio es un trastorno de almacenamiento de mucopolisacáridos se caracteriza principalmente por estatura corta y afectación ósea grave, pero el coeficiente intelectual es normal. La prevalencia es rara se estima que afecta a uno de cada 200.000 nacimientos hombres y mujeres por igual. La MPS IV A y B son enfermedades autosómicas recesivas con esto queremos decir que ambos progenitores son portadores del mismo gen afectado el cual se encuentra alterado produciendo así una deficiencia en la producción de la enzima. Las manifestaciones esqueléticas en esta displasia son retardo en el crecimiento, hipoplasia del odontoides, cifosis toracolumbar, displasia de cadera, genu valgo, manchas cutáneas y laxitud articular, en cuando a cuestiones dentales tenemos: el esmalte es delgado, rugoso e hipoplásico afectando dientes deciduos como permanentes. Se presenta el caso de un paciente masculino de 8 años 3/12 presentando MPS el cual requiere un protocolo de rehabilitación lo cual se realiza en el área de odontopedriatría del Hospital del Niño DIF.

Morquio syndrome is a mucopolysaccharide storage disorder is mainly characterized by short stature, severe bone involvement, but IQ is normal. The prevalence is rare is estimated to affect one in every 200,000 births men and women alike. The MPS IV A and B are autosomal recessive diseases with this we mean that both parents are carriers of the same gene affected which is altered thus producing a deficiency in the production of the enzyme. The skeletal manifestations in this dysplasia are growth retardation, hypoplasia of the odontoid, thoracolumbar kyphosis, hip dysplasia, genu valgus, skin blemishes and joint laxity, then dental issues are: the enamel is thin rugged and hypoplastic affecting deciduous theeth as permanent. The case of a male patient presenting eight years 3/12 MPS which requires a rehabilitation protocol which is done in the dental area of Hospital del Niño DIF is presented.

Assuntos

RESUMO

Autism spectrum disorders (ASD) may present with macrocephaly. Few studies have analyzed the association with psychiatric comorbidity. Participants were 94 children with any ASD with an age range from 2 to 16 years (Mdn 6 years), 82% were boys. It was found that 20% of the sample had macrocephaly and 1% microcephaly. There was no association between the presence of macrocephaly and subtype of ASD. The most associated comorbidity was attention-deficit/hyperactivity disorder (ADHD) 54.2%, followed by specific phobia 34%, dysthimia 29.7%, oppositional defiant disorder 13.83% motor tics 11.7%, separation anxiety 9.5% and Gilles de la Tourette 8.5%. In conclusion, macrocephaly and psychiatric comorbidity in this clinical sample of children with ASD is similar to the international literature results.

Assuntos

RESUMO

The Gorlin-Goltz syndrome (GGS) is a hereditary, autosomal dominant condition, with high penetrance and variable expressivity, resulting from mutations in the genes PTCH1, PTCH2, or SUFU. The diagnosis is based on the presence of 2 major criteria or a major criterion associated with 2 minor criteria, including multiple basal cell carcinomas, keratocystic odontogenic tumor (KOT), and bifid rib. Other endocrine, neurological, ophthalmologic, genital, respiratory, and cardiovascular alterations are found in the literature, but with variable manifestations. This study reports the case of a patient diagnosed with GGS associated with diastolic congestive heart failure and type 2 diabetes mellitus, who underwent multiple treatments for components of the syndrome. More recently, the patient underwent decompression followed by cystic enucleation of two KOTs in the jaw, oral rehabilitation with removable prosthodontics, cardiological evaluation, and attempted clinical control of endocrine and cardiac problems.

A síndrome de Gorlin-Goltz (SGG) é uma condição hereditária, autossômica dominante, com alta penetrância e expressividade variável, decorrente de mutações nos genes PTCH1, PTCH2 ou SUFU. O diagnóstico é baseado na presença de dois critérios maiores ou um critério maior associado a dois critérios menores, dentre eles múltiplos carcinomas basocelulares, tumor odontogênico ceratocístico (TOC) e costela bífida. Outras alterações endócrinas, neurológicas, oftalmológicas, genitais, respiratórias e cardiovasculares são encontradas na literatura, porém com manifestações variáveis. O objetivo deste trabalho é relatar um caso clínico de uma paciente sistematicamente diagnosticada com SGG associada à insuficiência cardíaca congestiva diastólica e diabetes mellitus 2 submetida a tratamentos seriados das respectivas manifestações sindrômicas. Mais recentemente, à descompressão cística seguida da enucleação de dois TOC em mandíbula, reabilitação oral com prótese total removível, avaliação cardiológica e tentativa de controle clínico das alterações endócrinas e cardíacas.

Assuntos

RESUMO

La acidemia glutárica tipo-1 es uno de los errores innatos del metabolismo diagnosticados con mayor frecuencia en Colombia. Es consecuencia de una alteración en el metabolismo de los aminoácidos lisina, hidroxilisina y triptófano, de la que resulta acumulación de ácidos glutárico y 3-hidroxiglutárico en los fluidos corporales. Clínicamente es un trastorno neurológico caracterizado por macrocefalia, atrofia cerebral progresiva y distonía. Por su evolución crónica es una enfermedad subdiagnosticada, de tal forma que pueden pasar varios años hasta que la sintomatología o las neuroimágenes sugieren la etiología metabólica. Sin embargo, algunos pacientes presentan la forma aguda usualmente desencadenada por una infección entre los 6 y 18 meses de edad. Por ser susceptible de manejo nutricional, es necesario hacer tempranamente el diagnóstico e iniciar el tratamiento, para prevenir o mejorar las complicaciones y enfermedades intercurrentes. Es de importancia considerar la AG-1 en el diagnóstico diferencial de pacientes con parálisis cerebral espástica o disquinética sin una historia clara de eventos hipóxicos, así como en pacientes con regresión en los hitos del neurodesarrollo. Se describe un caso con presentación aguda, que ilustra el curso clínico y el enfoque diagnóstico de la enfermedad.

Glutaric acidemia type I (GA-1) is a neurological disease of metabolic ethiology. Although considered rare, it is one of the most frequent inborn errors of metabolism in Colombia. GA-1 is caused by alterations in lysine, hydroxylysine and tryptophan metabolism, resulting in the accumulation of glutaric and 3-hydroxyglutaric acids in body fluids. Clinically, it is characterized by macrocephaly, progressive cerebral atrophy, and dystonia secondary to striatal degeneration. Due to its chronic evolution, it is usually under- diagnosed, so that several years may pass before suggestive symptoms or brain imaging findings are discovered. In some patients, the disease may appear acutely triggered by an infection between 6 and 18 months of age. Due to the availability of nutritional treatment, it is necessary to make an early diagnosis and to start treatment, in order to prevent or improve complications and associated diseases. It is important to consider GA-1 in the differential diagnosis of patients with spastic or dyskinetic cerebral palsy without a clear history of hypoxic events, as well as in patients with regression in neurological development. We report a case with acute presentation to exemplify the natural history of the disease and the diagnostic approach to it.

A Acidemia Glutárica tipo-1 é um dos erros inatos do metabolismo diagnosticados com maior frequência na Colômbia. É consequência de uma alteração no metabolismo dos aminoácidos lisina, hidroxilisina e triptófano, da que resulta acumulação de ácidos glutárico e 3-hidroxiglutárico nos fluidos corporais. Clinicamente é um transtorno neurológico caracterizado por macrocefalia, atrofia cerebral progressiva e distonia. Por sua evolução crônica é uma doença subdiagnosticada, de tal forma que podem passar vários anos até que a sintomatologia ou as neuroimagens sugerem a etiologia metabólica. No entanto, alguns pacientes apresentam a forma aguda usualmente desencadeada por uma infecção entre os 6 e 18 meses de idade. Por ser susceptível de manejo nutricional, é necessário fazer cedo o diagnóstico e iniciar o tratamento, para prevenir ou melhorar as complicações e doenças intercorrentes. É de importância considerar a AG-1 no diagnóstico diferencial de pacientes com paralisia cerebral espástica ou disquinética sem uma história clara de eventos hipóxicos, bem como em pacientes com regressão nas metas do neurodesenvolvimento. Descreve-se um caso com apresentação aguda, que ilustra o curso clínico e o enfoque diagnóstico da doença.

Assuntos

RESUMO

En la mayoría de los niños con macrocefalia no se encuentra una causagrave, sin embargo, deben considerarse en el diagnóstico etiológico cuadros tratables y/o progresivos como una hidrocefalia. Un análisis cuidadoso y ordenado de los datos obtenidos en anamnesis y examen físico/neurológico, y una adecuada valoración del desarrollo psicomotor permitirán definir las probables causas de la macrocefalia y exámenes complementarios, evitando realizar procedimientos innecesarios.

Although most children with macrocephaly do not have a serious cause, treatable or progressive disorders as hydrocephalus must be considered in the diagnostic workup. A careful and orderly analysis of data obtained from anamnesis and physical / neurological examination, and a proper assessment of psychomotor development will allow the definition of likely causes of macrocephaly and examinations to accomplish, avoiding performing unnecessary procedures.

Assuntos

RESUMO

El absceso cerebral concierne a una colección de pus localizada en el parénquima cerebral. Es muy poco frecuente en los niños lactantes, predominando en los jóvenes y personas de edad avanzada. Esta entidad se presenta con manifestaciones clínicas muy variable. Los agentes etiológicos son muy diversos pero predominan los Streptococos, Staphylococcus y la klebsiella. El diagnóstico se basa en el cuadro clínico, el examen físico y los complementarios. El tratamiento se adecua al estadio en el que se encuentre la lesión inflamatoria, el germen que la produzca, el tamaño de la lesión y la condición neurológica del paciente. En el presente trabajo se presenta un lactante de 4 meses de edad con antecedentes de haber tenido una infección respiratoria alta tres meses previos a su ingreso que un mes después comenzó con fiebre de 38-39° C asociado a irritabilidad y fontanela anterior ocupada, en la tomografía contrastada se evidenció imagen hipodensa en región frontal izquierda con gran efecto de masa y desplazamiento de las estructuras de la línea media. Fue puncionado dos días consecutivos donde se evacuaron 80 ml de pus amarillento, en cada proceder al 4to día se interviene quirúrgicamente con craneotomía frontotemporal izquierda y lobectomía frontal ipsilateral con resección de toda la cápsula. Se le mantuvo con tratamiento antibiótico por 3 semanas. En la resonancia magnética postoperatoria hubo una desaparición de los signos inflamatorios del encéfalo, su evolución posterior fue satisfactoria.

A cerebral abscess is defined as a collection of pus within the cerebral parenchyma. Though rare in infants, it is common among young patients and the elderly. The clinical manifestations are varied. The predominant etiological agents include Streptococci, staphylococci and klebsiella. A patient is diagnosed based on the clinical picture, the physical exam and complementary tests. Treatment options depend on the stage of the disease, its size, the causative agent, and the neurological condition of the patient. A case is presented of a four month old infant with a history of an upper respiratory tract infection three months prior to his admission. One month later, he exhibited a high fever of 38-39 °C with irritability and a tense anterior fontanel. The CT scan revealed a hypo dense lesion in the left frontal lobe with significant mass effect and midline shift. The lesion was punctured on two consecutive days and 80 ml of yellowish pus was removed on both occasions. Four days later, a left fronto-temporal craniotomy and an ipsilateral frontal lobectomy was performed, with complete excision of the capsule. Antibiotic therapy was continued for three weeks. The post op MRI confirmed the complete excision of the lesion and disappearance of the surrounding edema. Recovery was satisfactory

Assuntos